Presented by Johns Hopkins University School of Medicine Department of Oncology and Virginia Cancer Specialists
Date & Location
Saturday, March 10, 2018 7:00 AM – 5:00 PM
The Ritz-Carlton, Tysons Corner, McLean, VA
Who Should Attend:
This activity is intended for pulmonologists, thoracic surgeons, oncologists and radiation oncologists.
After attending this activity, the participant will demonstrate the ability to:
Download Brochure Here
- Identify the appropriate patients for multidisciplinary lung cancer care.
- Evaluate patients for the appropriate treatments (targeted, immunotherapy) where applicable.
- Formulate a plan for comprehensive management when multiple therapies are available.
- Management of toxicities of therapy that may require input from multiple specialties.
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
- American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
- American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA
PRA Category 1 Credit™ from organizations accredited by ACCME.
- Physician assistants may receive a maximum of 7.75 AAPA Category 1 CME credit(s) for completing this program.
The Johns Hopkins University has approved this activity for 7.75 contact hours for non-physicians.
The number of new lung cancer therapies for Non Small Cell Lung Cancer (NSCLC) have exploded over the past few years – so has the complexity of treatment, and the need to co-manage patients with a multidisciplinary approach. Oncologists who have traditionally worked independently, are now encouraged to collaborate with colleagues to ensure that the right procedures are followed and appropriate tissue is obtained for the correct treatment plan. It is our goal of this CME activity to bring together the community of medical professionals that co-manage these patients to optimize patient outcomes. Participants will gain insight into novel techniques for the staging of lung cancer,new surgical treatments, controversies in disease, immunotherapy advancements and the management of targeted therapies.
$165 for physicians
$125 for nurses, fellow, residents and other allied health professionals.
Topics to be Discussed:
- Novel Techniques for Staging of Lung Cancer (Interventional Pulmonology) / Dr. Bobby Mahajan
- Surgical Treatments of Lung Cancer / Dr. Stephen Broderick
- Thoracic Early Recovery with Ambulation After Surgery (T-ERAS) / Dr. Sandeep Khandhar
- Novel Approaches Towards Radiation / Dr. Russell Hales
- Panel Discussion: Controversies of Stage III Disease / Drs. Alexander Spira, Russell Hales, Stephen V. Liu, Bobby Mahajan, and Timothy A. McCarthy
- Biology of Immunotherapy Response and Toxicity / Dr. Stephen Liu
- Targeted Therapies / Dr. Alexander Spira
- Current and Future Status of Immunotherapy in Lung Cancer / Dr. David Ettinger
TO REGISTER or FOR FURTHER INFORMATION
Click either link below to register online (Johns Hopkins CME Website)
- Register Here
- Register by Phone (410) 502-9634
- Register by Fax (866) 510-7088
- Confirmation/Certificates/Transcripts (410) 502-9634
- General Information (410) 955-2959
E-mail the Office of CME email@example.com
Follow us on Twitter: http://twitter.com/HopkinsCME